70% of COVID mRNA vaccine doses have gone to the richest countries, so South African scientists are copying Moderna’s COVID vaccine
Credit: Afrigen Biologics
Many steps remain before Afrigen’s mRNA vaccine candidate can be distributed to people in Africa and beyond, and it definitely won’t help to curb the pandemic this year. But the WHO hopes that the process of creating it will lay the foundation for a more globally distributed mRNA-vaccine industry. Patrick Arbuthnot, director of gene-therapy research at the University of the Witwatersrand, says, “We were not intimidated, because mRNA synthesis is a fairly generic procedure.” Despite delays in the shipment of raw materials, the team completed this process in ten weeks and sent vials of mRNA to Afrigen in early December.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Coronapod: How African scientists are copying Moderna's COVID vaccinePharmaceutical companies have declined to license their COVID vaccines, so South African scientists have copied them instead
Baca lebih lajut »
Nordic combined-Norway hopeful Riiber can compete after negative COVID testNorway's Nordic combined athlete Jarl Magnus Riiber has tested negative for COVID-19 and could yet appear in competition at the Beijing Olympics this week, the team said on Sunday.
Baca lebih lajut »
Nearly a dozen states move to end masking mandates as COVID-19 infection rates fall
Baca lebih lajut »
New Jersey hot dog restaurant Designer Dawgs nearly crushed by COVIDOwner Holly Smith of Designer Dawgs in Clinton, New Jersey, talked to Fox News Digital about the enormous struggles of keeping her small business open through the pandemic.
Baca lebih lajut »
New York Fashion Week kicks off amid CovidBritish wunderkind Christian Cowan helped open New York Fashion Week with a riot of sequins, feathers and little T-shirts of love to the city he now calls home.
Baca lebih lajut »
Breakthrough COVID powers up immune response to variants — including OmicronExperiments suggest that SARS-CoV-2 infections after vaccination trigger antibody levels similar to those in people whose infections preceded their vaccination.
Baca lebih lajut »